Appili Therapeutics【APLI】銘柄情報

Appili Therapeutics Inc (APLI) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.015

( - )

買値

0.015

売値

0.02

出来高

58,300

0.015 日の範囲 0.015

0.01 52 週間の範囲 0.04

時価総額

1.985M

前日終値

0.015

始値

0.015

時刻

30000

0.015

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 94,271

発行済株式数

132,366,120

配当利回り

PER

-0.44

1 株当たり利益 (EPS)

-0.03

歳入

244.18k

純利益

-4.24M

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anae... Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

appilitherapeutics.com

本社

Halifax, Canada

設立

2026

Appili Therapeutics Inc is listed in the Healthcare sector of the トロント証券取引所 with ticker APLI. The last closing price for Appili Therapeutics was $0.02. Over the last year, Appili Therapeutics shares have traded in a share price range of $ 0.01 to $ 0.04.

Appili Therapeutics currently has 132,366,120 shares in issue. The market capitalisation of Appili Therapeutics is $1.99 million. Appili Therapeutics has a price to earnings ratio (PE ratio) of -0.44.

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01...

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Presentation Highlights Recent Collaborations and Funding Milestones Appili Executives to Conduct...

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia...

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding...

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia...

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across...

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Nov...

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF...

Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01

Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to...

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.015	0.015	0.01	15753	0.015	CS
4	0	0	0.015	0.015	0.01	29038	0.015	CS
12	0	0	0.015	0.02	0.01	57437	0.01631022	CS
26	-0.01	-40	0.025	0.025	0.01	44209	0.01798075	CS
52	0	0	0.015	0.04	0.01	95099	0.0284499	CS
156	-0.015	-50	0.03	0.08	0.01	124762	0.03884019	CS
260	-0.715	-97.9452054795	0.73	1.14	0.01	145813	0.10445437	CS